Showing results (321-330 of 339) with videos related to
Sort By:
Pageof 34
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.Journal of Biochemistry|November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.Leukemia|April 6, 2023
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibodyMarc S Raab, Yael C Cohen, Fredrik Schjesvold, et al.Blood|June 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effectKento Umino, Kaoru Morita, Takashi Ikeda, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2019
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese CohortChikako Ohwada, Emiko Sakaida, Aiko Igarashi, et al.Blood Advances|January 4, 2020
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, et al.Clinical and Experimental Medicine|August 22, 2025
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failureYoshitaka Zaimoku, Tatsuya Imi, Tatsuya Hatada, et al.Blood Advances|September 13, 2021
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaIsamu Sugiura, Noriko Doki, Tomoko Hata, et al.International Journal of Clinical Oncology|November 14, 2018
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2022
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience]Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Pageof 34